2024-09-18 - Analysis Report
## PFE Stock Analysis Report

**Company Overview:** Pfizer Inc. (PFE) is a multinational pharmaceutical corporation that develops and produces medicines and vaccines for a wide range of medical conditions.

**Performance Analysis:**

**1. Performance vs. S&P 500:**

* **Cumulative Return (PFE):** -24.88%
* **Cumulative Return (VOO):** 89.02%
* **Divergence:** -113.9 (Relative Divergence: 3.12)

PFE has significantly underperformed the S&P 500, lagging behind by over 113.9%. While the relative divergence suggests PFE has slightly outperformed the S&P 500 in the past, its current performance remains significantly lower.

**2. Recent Price Action:**

* **Closing Price:** $30.07
* **5-Day Moving Average:** $29.58
* **20-Day Moving Average:** $28.98
* **60-Day Moving Average:** $29.01

The price is currently above all moving averages, suggesting potential upward momentum. However, the recent trend is flattening, indicating a potential slowdown in price movement.

**3. Technical Indicators:**

* **RSI:** 63.92
* **PPO:** 0.46
* **Delta_Previous_Relative_Divergence:** 0.68 (Short-Term Downward Trend)
* **Expected Return:** 0.0%

The RSI indicates the stock is in slightly overbought territory, potentially suggesting a short-term correction may be coming. The PPO is positive, indicating upward momentum in price. However, the recent short-term downward trend in relative divergence suggests caution. The expected return is currently low, reflecting the current market conditions.

**4. Recent Earnings and Outlook:**

* **Latest Earnings (2024-07-30):** EPS = $0.6, Expected EPS = $0.458
* **Previous Earnings:**
    * 2024-05-01: EPS = $0.82, Expected EPS = $0.516
    * 2024-01-30: EPS = $0.1, Expected EPS = -$0.19
    * 2023-10-31: EPS = -$0.17, Expected EPS = -$0.32
    * 2023-08-01: EPS = $0.67, Expected EPS = $0.56

PFE has consistently beaten earnings expectations in recent quarters, showing strong performance. However, it's worth noting that the company's earnings growth is decelerating, and the current economic environment may continue to put pressure on future earnings. 

**5. Overall Analysis:**

PFE has been underperforming the broader market significantly, despite delivering strong recent earnings. While technical indicators show some upward momentum, the stock is currently in overbought territory, and the relative divergence points to a short-term downward trend. The expected return is currently low. Investors should monitor the stock closely, paying attention to future earnings reports and economic developments.

**6. Recommendations:**

Investors should carefully consider their investment goals and risk tolerance before making any decisions regarding PFE. Given the current market conditions and the potential for short-term correction, a cautious approach is recommended. Further research and due diligence are essential before making any investment decisions. 
